PFE - What's Going On With Pfizer Shares Wednesday? | Benzinga
Pfizer Inc. (NYSE:PFE) is experiencing notable stock movement on Wednesday afternoon. Here’s what you need to know.
What’s Going On: Pfizer is actively engaged in an open-label extension (OLE) study to evaluate the safety and efficacy of etrasimod in patients with moderately to severely active ulcerative colitis (UC). This study is an extension of previous Phase 2 and Phase 3 double-blind, placebo-controlled studies.
The OLE study is designed to treat participants with etrasimod 2 mg tablets, administered orally once daily for up to approximately eight years or until marketing authorization ...